Countries with greater resources are opening up for a more normal life. But COVID-19 and the SARS-CoV-2 virus are still a significant threat in large parts of the world. The lack of medicines that are effective, easy to distribute and easy to obtain are a significant part of the problem. However, recent research on a new drug combination is showing promising results. The combined use of nafamostat and Pegasys (IFNα) meets all availability and efficacy requirements.
- Post author:
- Post published:September 30, 2021
- Post category:Uncategorized